Clinical Trial Update: Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating a gene therapy for women with refractory or relapsed ovarian epithelial cancer, fallopian tube cancer, or primary pe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Gene Therapy

Snippet

Sponsor: John Stoddard Cancer Center at Iowa Methodist Medical Center | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: UNKNOWN